Diabetic Gastroparesis.
Open accessThe DOI matches its Crossref record; 349 of the 371 references it cites were found in a registry or an index; 47 of the 103 sources its claims cite were checked for support.
Abstract
This review covers the epidemiology, pathophysiology, clinical features, diagnosis, and management of diabetic gastroparesis, and more broadly diabetic gastroenteropathy, which encompasses all the gastrointestinal manifestations of diabetes mellitus. Up to 50% of patients with type 1 and type 2 DM and suboptimal glycemic control have delayed gastric emptying (GE), which can be documented with scintigraphy, 13C breath tests, or a wireless motility capsule; the remainder have normal or rapid GE. Many patients with delayed GE are asymptomatic; others have dyspepsia (i.e., mild to moderate indigestion, with or without a mild delay in GE) or gastroparesis, which is a syndrome characterized by moderate to severe upper gastrointestinal symptoms and delayed GE that suggest, but are not accompanied by, gastric outlet obstruction. Gastroparesis can markedly impair quality of life, and up to 50% of patients have significant anxiety and/or depression. Often the distinction between dyspepsia and gastroparesis is based on clinical judgement rather than established criteria. Hyperglycemia, autonomic neuropathy, and enteric neuromuscular inflammation and injury are implicated in the pathogenesis of delayed GE. Alternatively, there are limited data to suggest that delayed GE may affect glycemic control. The management of diabetic gastroparesis is guided by the severity of symptoms, the magnitude of delayed GE, and the nutritional status. Initial options include dietary modifications, supplemental oral nutrition, and antiemetic and prokinetic medications. Patients with more severe symptoms may require a venting gastrostomy or jejunostomy and/or gastric electrical stimulation. Promising newer therapeutic approaches include ghrelin receptor agonists and selective 5-hydroxytryptamine receptor agonists.
Overview
CoChat Summary
TL;DR
This review synthesizes the epidemiology, pathophysiology, clinical features, diagnosis, and management of diabetic gastroparesis and the broader diabetic gastroenteropathy. It emphasizes that delayed gastric emptying is common but often asymptomatic, and that management is guided by symptom severity, degree of emptying delay, and nutritional status.
Key findings
- Up to 50% of patients with type 1 and type 2 diabetes mellitus and suboptimal glycemic control have delayed gastric emptying; the remainder have normal or rapid emptying. Many with delayed emptying are asymptomatic, while up to 50% of patients have significant anxiety and/or depression.
- In Olmsted County, the age-adjusted prevalence of definite gastroparesis per 100,000 persons was higher in women (37.8; 95% CI, 23.3–52.4) than men (9.6; 95% CI, 1.8–17.4); 25% of definite, 31% of definite/probable, and 46% of any-definition gastroparesis cases had diabetes.
- Over 10 years, gastroparesis developed in 5% of type 1 diabetes (HR, 33; 95% CI, 4.0–274 vs controls), 1% of type 2 diabetes (HR, 7.5; 95% CI, 0.8–68), and 1% of controls; risk was greater in type 1 than type 2 diabetes (HR, 4.4; 95% CI, 1.1–17). In the T1D Exchange registry, 4.8% had a clinical diagnosis of gastroparesis, higher in women (5.8%) than men (3.5%).
- Pathogenesis implicates hyperglycemia, autonomic neuropathy, and enteric neuromuscular inflammation/injury; full-thickness gastric biopsies show loss of interstitial cells of Cajal, loss of enteric nerves, and immune infiltrate, with ICC number correlated with faster 4-hour gastric emptying. Management includes dietary modification, supplemental oral nutrition, antiemetics/prokinetics, and for severe symptoms venting gastrostomy/jejunostomy and/or gastric electrical stimulation; newer approaches include ghrelin receptor agonists and selective 5-hydroxytryptamine receptor agonists.
Methods
- Narrative review covering epidemiology, pathophysiology, clinical features, diagnosis, and management of diabetic gastroparesis and diabetic gastroenteropathy.
- Evidence is drawn from cited clinical and population-based studies, including Olmsted County/Rochester Epidemiology Project studies, the T1D Exchange clinic registry, the NIDDK consortium, and the Nationwide Inpatient Sample.
- Included studies generally defined delayed gastric emptying by objective assessment with scintigraphy, a wireless motility capsule, or a gastric emptying breath test; scintigraphy is described as the criterion standard.
Limitations
- The paper states that no studies have evaluated the prevalence of delayed gastric emptying among randomly selected community members; population-based studies were based on patients who sought care, and the T1D Exchange diagnostic criteria are unclear. It also notes that Nationwide Inpatient Sample data are not broken down separately for idiopathic and diabetic gastroparesis, and that the extent to which survival is affected by comorbid conditions or gastroparesis severity is unknown.
- The paper notes that distinguishing dyspepsia from gastroparesis is often based on clinical judgement rather than established criteria, and that it is uncertain whether quality-of-life differences exist between idiopathic and diabetic gastroparesis.
- Evident from the provided text: the full article is truncated, so later sections on diagnosis and management are not fully available for summary; as a review, it reports no new primary data.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
37 Valid · 11 Not valid · 40 Not checked · 14 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Autonomic dysfunctions are correlated with GI dysmotility (56) and cardiovascular vagal dysfunction is associated with delayed GE in some (58, 59), but not all, studies (1).”
What the sources say
- Supportedcites [58] Bharucha, 2015, Delayed gastric emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitus, Gastroenterology source
The citation is attached to “but not all, studies.” In the Results (Relationship between Complications of DM and Gastric Emptying – Univariate Analysis; page unavailable), this study found no statistically significant difference in the prevalence of defined cardiac autonomic neuropathy between delayed- and normal-GE groups, although a separate measure of cardiovagal function was associated with delayed GE. It therefore supports the cited exception, with that measurement distinction. (LLM, conf=0.87)
- Disputedcites [59] Bharucha, 2015, Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes, Clin Gastroenterol Hepatol sourceExperimental — accuracy not yet measured
The citation to this paper is attached to the claim that some studies did not find an association. The paper’s Discussion instead says vagal dysfunction was associated with delayed gastric emptying in this study; the Results report the association at P<.05. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Supportedcites [1] Chakraborty, 2019, GI dysfunctions in diabetic gastroenteropathy, their relationships with symptoms, and effects of a GLP-1 antagonist, J Clin Endocrinol Metab source
The citation to this paper is attached to the “but not all studies” qualification. In the Cardiovascular autonomic nervous functions section, the study reports that vagal dysfunction was not associated with slower gastric emptying of solids among patients with diabetes. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The overall age-adjusted prevalence of definite gastroparesis per 100,000 persons was approximately fourfold higher in women (37.8; 95% CI, 23.3, 52.4) than in men (9.6; 95% CI, 1.8, 17.4).”
What the sources say
- Supportedcites [4] Jung, 2009, The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006, Gastroenterology source
The Results section, under “Incidence and prevalence of gastroparesis,” reports age-adjusted prevalence of definite gastroparesis of 37.8 per 100,000 women (95% CI, 23.3–52.4) and 9.6 per 100,000 men (95% CI, 1.8–17.4). It gives a female-to-male ratio of 3.9:1, consistent with “approximately fourfold.” (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Among the patients enrolled in this registry who were >26 years of age and had DM for at least 2 years, 4.8% received a clinical diagnosis of gastroparesis (13).”
What the sources say
- Partly supportedcites [13] Aleppo, 2017, Reported gastroparesis in adults with type 1 diabetes (T1D) from the T1D Exchange clinic registry, J Diabetes Complications sourceExperimental — accuracy not yet measured
The Subjects, materials, and methods passage defines the cohort as participants aged ≥26 years with T1D for at least two years, and the Results report a clinical gastroparesis diagnosis in 4.8% of that cohort. The citing sentence says >26 years, which excludes 26-year-olds included in the reported figure. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Because the study only captured patients who presented for care, it does not include people who did not have a GE study.”
What the sources say
- Partly supportedcites [6] Choung, 2012, Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population, Am J Gastroenterol sourceExperimental — accuracy not yet measured
The Discussion says the study may have missed people who did not visit a physician for gastroparesis symptoms, supporting the care-seeking limitation. But Methods > Ascertainment of Gastroparesis says potential cases were identified through either a diagnostic index or a gastric-emptying test database; it does not make a gastric-emptying study a requirement for inclusion. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The risk of gastroparesis was greater in type 1 DM than in type 2 DM (HR, 4.4; 95% CI, 1.1, 17).”
What the sources say
- Supportedcites [6] Choung, 2012, Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population, Am J Gastroenterol source
The Results section (‘Gastroparesis in Subjects with Type 1 or 2 DM versus Controls’) directly reports a significantly greater risk of developing gastroparesis in type 1 than type 2 DM, with HR 4.4 and 95% CI 1.1–17. No page number is supplied for the passage. (LLM, conf=0.95)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
52 more claims · 17 with their cited sources checked
Create a free account to see all 102 claims and every source verdict.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 15
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in the gastric fundus, impaired inhibitory neurotransmission is accompanied by reduced tonic contraction because of defective muscle contractility, whereas in the antrum both cholinergic neuromuscular transmission and smooth muscle strength are altered [19, 23, 42, 43].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In diabetes, chronic hyperglycemia, and reduced trophic factors, in particular the reduction of KIT/stem cell factor (SCF), cause the loss or dysfunction of ICCs [52], leading to dysregulated gastric emptying [4, 19, 53].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while psychological factors (anxiety, depression, and somatization) may modulate symptom severity despite similar objective findings [4, 18–20].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The interplay between autonomic neuropathy, impaired enteric neurotransmission, and loss or dysfunction of interstitial cells of Cajal produces a motility disorder that disrupts the temporal coordination between meal ingestion, gastric processing, intestinal absorption, and insulin pharmacodynamics.”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [19]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As a consequence, gastroparesis profoundly affects postprandial glycemic excursions, insulin requirements, and the overall management of diabetes [15, 19, 23, 88, 89].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Abstract
“During 10 years, gastroparesis developed in 5.2% (DM1), 1% (DM2), and 0.2% (controls)”
§ Abstract
“The cumulative incidence of symptoms and delayed GE during 10 years was 5% in type 1 DM [hazard ratio (HR), 33; 95% CI, 4.0, 274, adjusted for age and sex vs controls], 1% in type 2 DM (HR, 7.5; 95% CI, 0.8, 68, adjusted for age and sex vs controls), and 1% in controls.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Follow-up of 1374 patients (269 with DM1, 409 DM2) and controls matched for age and sex (735) in Olmsted County, MN”
Reported 1374 · recomputed 1413
Citations
Cites
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Depression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799
Stanghellini, V., Chan, F. K. L., Hasler, W. L., Malagelada, J. R., Suzuki, H., Tack, J., & Talley, N. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.011 · Cited by 1,572
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
Clinical Guideline: Management of Gastroparesis
Camilleri, M., Parkman, H. P., Shafi, M. A., Abell, T. L., & Gerson, L. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.373 · Cited by 1,149
Azithromycin and the Risk of Cardiovascular Death
Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1003833 · Cited by 954
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Cited by
Items 101–200 of 246
Ni, Q., Wu, C., Lang, D.-Q., Cai, W., Chen, Q.-C., Jiang, C., Yi, Y., Liu, L., & Shen, C. (2025) · Industrial Crops and Products · doi:10.1016/j.indcrop.2025.121466 · Cited by 4
Data mining–based analysis to explore the application of an animal model of diabetic gastroparesis
Xu, H., Miao, F.-R., He, Y., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1612473 · Cited by 4
Ingestible electronic capsules for in situ sensing of diverse biomarkers
Zhang, C., Song, H., Zeng, J., Chen, J., Ni, C., Chung, H. U., Xu, K., Ying, B., & Nan, K. (2025) · Device · doi:10.1016/j.device.2025.100935 · Cited by 4
Zhu, Y., Sarosiek, I., Sun, Y., Yin, J., Abell, T. L., Nojkov, B., McCallum, R. W., & Chen, J. D. Z. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70184 · Cited by 5
Stott, M. C., Stefanova, I., Oldfield, L. S., Evans, A. G., Birch-Ford, J., Rao, R. G., Greenhalf, W., Halloran, C. M., & Costello, E. (2025) · Annals of Surgery Open · doi:10.1097/as9.0000000000000584 · Cited by 6
“37,38 However, the literature is inconsistent regarding the impact of preoperative diabetes on the development of DGE post-PDAC resection.”
Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis
Vélez, C. D., Freedman, S. D., & Assis, D. N. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.07.001 · Cited by 5
New insights into muscularis macrophages in the gut: from their origin to therapeutic targeting
Zhou, L., Lian, H., Yin, Y., Zheng, Y., Han, Y., Liu, G.-Q., & Wang, Z. (2023) · Immunologic Research · doi:10.1007/s12026-023-09397-x · Cited by 4
Zheng, X., Zhang, Y., Xu, J., Li, X., Wen, H., Zhang, X., Liu, A., & Zhang, J. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2808164 · Cited by 5
Liu, R., He, M., Zhao, X., Sun, M., Cao, J., Wang, X., Wang, X., Zhao, S., Wang, F., & Li, T. (2024) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2024.01.008 · Cited by 5
Varma, R., Chakraborty, S., Ramu, S. K., Burton, D. D., Deb, B., Ryks, M. D., Feuerhak, K. J., Bailey, K. R., & Bharucha, A. E. (2024) · Neurogastroenterology & Motility · doi:10.1111/nmo.14857 · Cited by 5
“21,22,31,32”
Self-citationA bibliometric analysis of diabetic gastroparesis from 1979 to 2024
Xu, H., Miao, F.-R., & Fan, Y.-S. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1445276 · Cited by 4
“We conducted a systematic and comprehensive bibliometric analysis of studies on DGP from 1979 to the present using Vosviwer 4.2 Keywords DGP (21) refers to the gastrointestinal symptoms associated with diabetes mellitus.”
BackgroundMethodInfluentialChangri, L., Sun, H., Bao, Y., et al. (2024) · Cell Biology International · doi:10.1002/cbin.12253 · Cited by 4
Yagyu, T., Yakami, Y., & Bando, T. (2024) · Journal of Medical Case Reports · doi:10.1186/s13256-024-04487-2 · Cited by 4
Wang, Z., Liu, T., Cao, D., Luo, H., Yang, Z. R., Kang, X., & Pan, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0302809 · Cited by 11
Analysis of gastric electrical rhythm in patients with type 2 diabetes mellitus
Wang, X., Ma, L., Jiang, M., Zhu, H., Ni, C., Yang, X., Hu, J., & Zhang, H. (2024) · Endocrine · doi:10.1007/s12020-024-03908-y · Cited by 5
“Diabetic autonomic neuropathy is currently recognized as one of the main pathophysiological foundations of DGMD [14, 15].”
BackgroundRayner, C. K., Jones, K. L., & Horowitz, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00018-1 · Cited by 4
Goyal, M. K. (2024) · Journal of Diabetes Research Review & Reports · doi:10.47363/jdrr/2024(6)183 · Cited by 3
Zhang, N., Zhang, S., Xie, L., Lu, H., Wang, Q., Xiong, Z., Wu, Z., Zhang, J., Jian, Y., Huang, W., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1636685 · Cited by 3
“(iii) Gastrointestinal complications may induce malabsorption: Studies demonstrate that chronic hyperglycemia and insulin resistance can compromise digestive system function, thereby impairing the digestion and absorption of nutrients (82, 83).”
Fan, M., Tian, J.-L., Zhang, S.-H., Zhao, Z.-J., Liu, X.-R., Liu, C.-X., & Chen, Y. M. N. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i2.114252 · Cited by 3
Liu, Q., Liu, R., Yang, J., & Li, J. (2026) · International Journal of Endocrinology · doi:10.1155/ije/2774096 · Cited by 3
Meta‐Analysis: Prevalence and Incidence of Gastroparesis Following Lung or Heart Transplantation
Eldesouki, M. H., Marey, M. M., Ali, M. A., Genidy, A. M., Gamal, M. H., Othman, A., Mohamed, A. N., Qady, A. A., Amaris, M. A., & Sharma, A. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70635 · Cited by 3
Khandelwal, D., Mathur, V., Sharma, D., & Vyas, A. (2022) · Neurology Asia · doi:10.54029/2022ayc · Cited by 4
Yuan, H.-L., Zhang, X., Chu, W., Lin, G.-B., & Xu, C.-X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26221 · Cited by 4
“Some patients present with only uncontrollable postprandial hyperglycemia or repeated hypoglycemia attacks, whereas some patients have no discomfort [9,10].”
BackgroundResultInfluentialKimura, Y., & Taniguchi, M. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106249 · Cited by 6
Panenteric Transit Times and Contractile Activity in Diabetic Gastroenteropathy
Kornum, D. S., Brock, C., Okdahl, T., Bertoli, D., Kufaishi, H., Wegeberg, A., Høyer, K. L., Mark, E. B., Brock, B., Hansen, C. S., et al. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm24126 · Cited by 5
“3,15,16 Two other wireless motility capsule studies did not observe correlations between gastrointestinal contraction frequencies and symptoms of gastroparesis in their sub-groups of individuals with diabetes.”
InfluentialJiang, J.-Z., Li, W.-Q., Kuang, K.-L., Jiang, Y., He, Z., Zhang, L., Cao, J.-Y., Wang, D., Zhang, X., Tian, Z.-L., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1536567 · Cited by 3
Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus
Mbakop, R. N. S., Kesiena, O., Greene, T., & Amakye, D. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.938418 · Cited by 3
Pathogenesis and endoscopic treatment of gastroparesis
Wu, Y., Xie, N., Yu, Y., & Li, B. (2023) · Gastroenterology & Endoscopy · doi:10.1016/j.gande.2022.11.008 · Cited by 3
Renard, É., Tubiana‐Rufi, N., Chaillous, L., Bonnemaison, É., Hanaire, H. P., Bismuth, É., Joubert, M., Coutant, R., Schaepelynck, P., Beltrand, J., et al. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.04.002 · Cited by 13
Clinical study status of diabetic gastrointestinal diseases
Fan, X., Wang, Y., Cao, J., Yu, J., Tian, J., & Mi, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1568552 · Cited by 5
External application of traditional Chinese medicine to treat diabetic gastroparesis
Li, S., & Wang, G. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.07.184 · Cited by 2
Chen, X.-X., Tao, L., & Wang, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01810-9 · Cited by 5
“…al. [20] suggests that very high fiber intake may alter the gut microbiota composition, potentially disrupting the production of beneficial short-chain fatty acids; (3) for patients with diabetic gastroparesis, excessive fiber may further delay gastric emptying and impair nutrient absorption [21].”
Bortolotti, M. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i23.104932 · Cited by 2
Key variables associated with gastroparesis in diabetes patients with gastroparesis-like symptoms
Bekkelund, M., Steinsvik, E. K., Valeur, J., Søfteland, E., Dimcevski, G., & Sangnes, D. A. (2025) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2025.2531038 · Cited by 2
Tan, R. J. L., Ahuja, A., Shrestha, A., Gallen, G., Stotesbury, B., Cheah, Y., Mustafa, O. G., Whyte, M., Croos, J., Shooshtarian, A. K., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70575 · Cited by 2
An early scientific report on acromegaly: solving an intriguing endocrinological (c)old case?
Quaranta, M., Orsini, E., Zoli, M., Ratti, S., Maltoni, L., Leonardi, L., & Manzoli, L. (2020) · HORMONES · doi:10.1007/s42000-020-00175-0 · Cited by 3
The role of mosapride and levosulpiride in gut function and glycemic control in diabetic rats
Akrab, S. N. A., Gawhary, N. E. A., Shafik, A. N., Morcos, G. N. B., & Wissa, M. Y. (2023) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2023.01.008 · Cited by 3
Diabetes-Related Gastroparesis in the Acute Care Setting: A Case Report
Batty, K., Pugh, P., Schwartzbauer, A., Carvalho, T., & Demidowich, A. P. (2023) · AACN Advanced Critical Care · doi:10.4037/aacnacc2023730 · Cited by 2
An overview of systematic reviews of acupuncture for diabetic gastroparesis
Li, T., Yu, M., Han, L., Feng, B., & Sun, F. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1196357 · Cited by 5
“The criteria for exclusion of articles were as follows: (1) Protocol of SR/MA, net meta-analysis, meeting abstracts, guidelines, animal experiments, or non-RCT SR/MA; (2) SR/MA comparing different acupuncture categories; and (3) SR/MA that was published twice or from which data could not be extracted.”
BackgroundMethodResultInfluentialInoue, S., Yasuda, H., Kamiya, T., & Okamoto, H. (2023) · Cureus · doi:10.7759/cureus.49075 · Cited by 4
“Diabetic gastroparesis, particularly prevalent in long-standing type 1 diabetes patients with complications [3], poses a significant clinical challenge due to its destabilizing effect on blood glucose control and its adverse impact on quality of life [4].”
BackgroundApplication of acupuncture in diabetic gastroparesis: A case series
Cao, J., Zhou, X., Yan, H., & Li, L. (2023) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2023.11.100 · Cited by 2
Vašátko, M., Evinová, E., Hugová, K., Simkova, D., Yepishkina, K., Amin, S., & Martínek, J. (2024) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2024.101910 · Cited by 3
Diabetic Gastroparesis: Epidemiology, Pathophysiology, Symptoms, and Clinical Consequences
Dróżdż, O., Gacka, P., Dołęga, M., Musialska, D., Rabczyński, M., Gołda, J., Mężyk, J., & Snopkowska, A. (2024) · Quality in Sport · doi:10.12775/qs.2024.21.53928 · Cited by 3
Garg, S., Valencia, S., Syed, H., Elkin, B. R., Shah, R., Bena, J., Morrison, S. L., Lembo, A., & Cline, M. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-08954-8 · Cited by 1
Jing, S., Chen, H., Bao, L., Lyu, R., Xu, B., Pu, L., Bian, X., Tao, L., & Wang, M. (2025) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2025.102066 · Cited by 5
Yan, H., An, Y., Zhang, T., Zhao, J., & Yan, J. (2021) · Medicine · doi:10.1097/md.0000000000027964 · Cited by 2
Adeno‐associated virus‐9 reverses delayed gastric emptying of solids in diabetic mice
Li, X., Ji, S., Cipriani, G., Hillestad, M. L., Eisenman, S. T., Barry, M. A., Nath, K. A., Linden, D. R., Wright, A. M., AlAsfoor, S., et al. (2023) · Neurogastroenterology & Motility · doi:10.1111/nmo.14669 · Cited by 2
Ultrasonography findings in diabetes and diabetes gastroparesis: A meta-analysis
Simadibrata, M., Utari, A. P., Siswoyo, A. D., Anastasia, E. S., Siregar, T. P., & Purnamasari, D. (2023) · F1000Research · doi:10.12688/f1000research.128672.1 · Cited by 3
Vaganova, A. N., Markina, A. A., Belousov, A. M., Ленская, К. В., & Gainetdinov, R. R. (2024) · Biomedicines · doi:10.3390/biomedicines12071590 · Cited by 2
“The drugs used for symptom relief in dyspeptic diseases like diabetic gastroparesis or functional dyspepsia (FD) usually include prokinetics and antiemetics [27,29], including antiemetics that demonstrate an antagonistic effect on D2 receptors such as metoclopramide or domperidone [29–31].”
BackgroundHan, L., Peng, Q.-Y., Yu, J., Liu, Y., Li, W., Ping, F., Zhang, H., Li, Y.-X., & Xu, L. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i15.101695 · Cited by 1
Ma, X., Jiang, B., Wan, S., & Wei, Z. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120676 · Cited by 2
Emerging roles of traditional Chinese medicine in the treatment of diabetic gastroparesis
Zhang, H., You, Q., Feng, X., & Qin, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1680943 · Cited by 2
“However, these methods may lead to drug resistance, poor efficacy, and other adverse effects such as arrhythmia, hyperprolactinemia, bleeding and ulceration, which limit their clinical application in patients with DGP (2, 6).”
Phlorizin-integrated magnetic pollen micromotors for diabetes complication management
Zhou, M., Yang, X., Li, H., & Shang, L. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102582 · Cited by 2
Duodenal myoelectrical hyperactivity drives diabetic remission in rat models of type 2 diabetes
Yun, Y., Liu, Y.-D., Yang, Z.-M., Wang, Y.-Q., Zhang, N., Li, W.-J., Gao, D., & Sha, L. (2025) · Diabetologia · doi:10.1007/s00125-025-06642-w · Cited by 1
“Diabetes induces complex and often paradoxical motility disturbances, ranging from accelerated intestinal transit in individuals [30] and postprandial hyper-contractility in animal models [31] to gastroparesis in late-stage disease [32].”
Wei, Y., Liu, K., Lu, X., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-106269 · Cited by 1
Naruse, S., Kasai, T., Kojima, M., Ueda, H., Akinaga, C., & Nakajima, Y. (2025) · JA Clinical Reports · doi:10.1186/s40981-025-00832-6 · Cited by 1
“In parturients with diabetes, the risk of aspiration is increased by gastropa-resis [19], supporting the use of neuraxial techniques; however, metabolic acidosis, autonomic dysfunction, and dehydration may exacerbate hypotension induced by sympathetic blockade [20, 21].”
Zhu, K., Wang, S.-J., Li, J. P., Ma, P., Feng, S., Guo, L., Lu, Y.-B., Dong, L., & Ding, D. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i2.112859 · Cited by 1
Diabetic Gastroparesis in Evolution
Eubanks, A., Jehu, D. A., Obineme, C. G., & Sharma, A. (2026) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002381 · Cited by 1
Chakraborty, S. (2026) · Open Medicine · doi:10.1515/med-2026-1428 · Cited by 1
“The association between pain and diabetes is supported by research in diabetic gastroparesis, which is often driven by autonomic neuropathy and frequently accompanied by more severe symptoms and a blunted symptom improvement relative to non-diabetics [28].”
Szarpak, L., Maslyk, M. M., & Aleksandrowicz, D. (2026) · British Journal of Anaesthesia · doi:10.1016/j.bja.2026.04.060 · Cited by 2
Barney, V. C., Parra, P., & Meza, Á. L. (2021) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.7.4.653 · Cited by 2
Pathological changes in the gastrointestinal tract in patients with diabetes mellitus
Aslanov, B. I., Чиркина, Т. М., Kokovina, Y. V., Antonova, E. A., Tiselko, A. V., Shirai, O., & Ignatova, O. K. (2023) · Medical alphabet · doi:10.33667/2078-5631-2022-35-29-36 · Cited by 1
Characteristics of digestive system lesions in patients with diabetes mellitus
Chentsov, D. V., Kokovina, Y. V., Aslanov, B. I., Чиркина, Т. М., & Tiselko, A. V. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-207-11-216-226 · Cited by 1
BÜBERCİ, R., Şirali, S. K., & Duranay, M. (2023) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2022-91804 · Cited by 1
Neurology and the gut: Autonomic neuropathy and dysautonomia
Ghafoor, A., Sundar, S., Karunaratne, T. B., Rao, S. S. C., & Sharma, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-13911-6.00028-1 · Cited by 1
Nutritional Risk of Candidates for Simultaneous Pancreatic–Kidney Transplantation—A Narrative Review
Mizerska, A., Durlik, M., & Kędzierska-Kapuza, K. (2023) · Nutrients · doi:10.3390/nu15194179 · Cited by 2
“The result of this might be early satiety, nausea, and vomiting, all of which additionally impair the patient’s nutritional status [38,39].”
BackgroundIndices of Nutrition Status of Kidney and Pancreas Transplant Candidates
Kędzierska-Kapuza, K., Safranow, K., Niewiński, K., Niewiński, G., Durlik, M., & Szczuko, M. (2024) · Transplantation Proceedings · doi:10.1016/j.transproceed.2024.03.012 · Cited by 1
Small Intestinal Slow Wave Dysrhythmia and Blunted Postprandial Responses in Diabetic Rats
Zhu, Y., Gong, S., Li, S., Li, Y., Wang, Y., Wu, G., & Chen, J. D. Z. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.14993 · Cited by 1
Domination of Gastric Complications Among Diabetic Patients
Mohiuddin, A. K. (2019) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2019.08.838 · Cited by 1
Gastrointestinal Symptoms in Patients with Diabetes
Kim, M.-K. (2019) · Journal of Korean Diabetes · doi:10.4093/jkd.2019.20.4.210 · Cited by 1
Konür, Ş. (2020) · Archives of Medical Science - Civilization Diseases · doi:10.5114/amscd.2020.100979 · Cited by 1
The Incidence of Erosive Esophagitis as a Complication of Pediatric Diabetic Ketoacidosis
Agrawal, S., Uysal, S., Fredette, M. E., Topor, L. S., Bialo, S. R., Herzlinger, M. I., Shapiro, J. M., Snelling, L. K., Boney, C. M., & Quintos, J. B. (2021) · Case Reports in Endocrinology · doi:10.1155/2021/6636383 · Cited by 1
“-e -e T1D Exchange Registry found that 4.8% of adult patients with a diabetes duration of at least 2 years were clinically diagnosed with gastroparesis [11, 12].”
InfluentialDonatini, B., & Le Blaye, I. (2021) · Journal of Clinical Case Studies · doi:10.16966/2471-4925.216 · Cited by 1
The Physiology and Pharmacology of Diabetic Gastropathy Management
Dolan, R. D., Rohani, T. S., Muttineni, D., & Mashimo, H. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00045-1 · Cited by 1
Gastrointestinal Manifestations of Endocrine Disease
Pandya, N., & Hames, E. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_88-1 · Cited by 1
Gastrointestinal Manifestations of Diabetes
Camilleri, M., & Bharucha, A. E. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch55 · Cited by 1
Self-citationDiabetic gastroparesis: pathophysiology and impact on insulin timing choices
Galeano, F., Tumminia, A., Oteri, V., Le Moli, R., Piticchio, T., Scilletta, S., Di Marco, M., Di Pino, A., & Frasca, F. (2026) · Endocrine · doi:10.1007/s12020-026-04693-6
Bando, H., Kato, Y., Kato, Y., Yamashita, H., Yada, S., & OGURA, K. (2021) · Diabetes Research - Open Journal · doi:10.17140/droj-7-150
Stainforth-Dubois, M., & McDonald, E. G. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.202091-f
Pecoraro, A., Duboc, H., & Moszkowicz, D. (2021) · Surgery Open Digestive Advance · doi:10.1016/j.soda.2021.100022
Letter to editor ‘Gastroenteropathy in gastric cancer patients concurrent with diabetes mellitus’
Cheng, Y.-X., Tao, W. Y., Zhang, W., & Peng, D. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i11.1967
Dhingra, V., Jain, S., Kant, R., & Kumari, R. (2021) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_112_20 · Cited by 1
Gastroenterologische Komplikationen des Diabetes mellitus: Gastroparese
Weber, A.-L., Leitolf, H., & Wedemeyer, H. H. (2021) · Gastroenterologie up2date · doi:10.1055/a-1502-4925
“Die ersten Ergebnisse zur Verbesserung der Symptomatik sind vielversprechend, auch wenn Patienten mit diabetischer Gastroparese möglicherweise weniger profitieren [13].”
BackgroundInfluentialSoliman, H., Mariano, G., Duboc, H., Giovinazzo, D., Coffin, B., Gourcerol, G., & Moszkowicz, D. (2022) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2022.01.003
Domination of Gastric Complications among Diabetic Patients
Mohiuddin, A. K. (2019) · Gastroenterology Open Access Open Journal · doi:10.33169/gastro.goaoj-i-101
Gastrointestinal Manifestations of Endocrine Disease
Pandya, N., & Hames, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_88
ABORDAGEM TERAPÊUTICA DA GASTROPARESIA DIABÉTICA
Cândido, R. S. G., de Souza, T. B. D., & Alves, H. B. (2022) · Revista Contemporânea · doi:10.56083/rcv2n3-036
Diagnosis and Treatment of Postoperative Gastroparesis for Gastric Cancer
聂, 世. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1281057
Emésztőrendszeri rendellenességek cukorbetegségben
Szigeti, N., & Wittmann, I. (2022) · Diabetologia Hungarica · doi:10.24121/dh.2022.10
Advances in the Application of Preoperative Oral Carbohydrates in Patients with Diabetes Mellitus
李, 鹏. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.131080
Miles, M., Woo, M. M. K., & Nasser, Y. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.221069
Muscularis Macrophages in Healthy and Diseased Gut
Mischopoulou, M., & Cipriani, G. (2023) · Physiology · doi:10.5772/intechopen.109889
Miles, M., Woo, M. M. K., & Nasser, Y. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.221069-f
Madhu, S., & Raizada, N. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_63_24
“[9] This implies that the mere absence of autonomic neuropathy should not prevent the clinician from considering a diagnosis of DGP.”
BackgroundWu, X., Yang, Z., Zhi-hong, L., Yang, L., Wang, X., Wang, C., & Gu, J. (2020) · Figshare · doi:10.6084/m9.figshare.12643794
李, 慧. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441309
Diabetic Gastroparesis: Diagnosis, Management, and Future Perspectives
Dołęga, M., Dróżdż, O., Gacka, P., Musialska, D., Gołda, J., Mężyk, J., & Snopkowska, A. (2024) · Quality in Sport · doi:10.12775/qs.2024.19.53973
Editorial: Gastrointestinal autonomic disorders
Tustumi, F., Ho, V., Payne, S. C., & Carra, R. B. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1492409
Prevalence and Severity of Diabetic Gastroparesis Symptoms in Relation to Diabetics in Saudi Arabia
Yaghmour, K. A., Shamrani, N. A. A., Alshamrani, F. M., et al. (2024) · Cureus · doi:10.7759/cureus.71920
“This is mostly because diabetes can cause continuous damage to the vagus nerve, which holds control of the mobility of food through the digestive tract [4].”
Aldali, J. A., Asseri, M. K., Almufarrij, H. A., Alromih, A. M., Al-Ajlan, A. R., Alrashed, K. A., ALghadeer, A. I., Almutawa, B. I., & Alshalani, A. (2024) · Gastroenterology Research and Practice · doi:10.1155/grp/3713569
“Therefore, the most common GI adverse e ff ects reported by patients using metformin tablets are diarrhea, nausea, and vomiting, with a prevalence of 2% – 63%, which are experienced with metformin more frequently than those with any other oral antidiabetic medication [16, 17].”
Metadata
- Authors
- Bharucha, A. E., Kudva, Y. C., & Prichard, D. O.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Bharucha, Adil E
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-05-13
- Volume
- 40
- Issue
- 5
- Pages
- 1318-1352
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC6736218
- OpenAlex
- W4211130106
- Cited by
- 252
- References
- 371
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 39 · 2023: 42 · 2022: 26 · 2021: 33 · 2020: 13 · 2019: 8
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (PO1 DK68055)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic gastroparesis, delayed gastric emptying, dyspepsia, autonomic neuropathy, hyperglycemia, gastric motility, prokinetic agents, antiemetics, nutritional support, gastric electrical stimulation, ghrelin receptor agonist, serotonin receptor agonists, quality of life, anxiety and depression
- MeSH terms
- Animals, Diabetic Neuropathies, Female, Humans, Male, Gastroparesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.